KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Depreciation and Depletion: 2009-2025

Historic Depreciation and Depletion for Quest Diagnostics (DGX) over the last 17 years, with Sep 2025 value amounting to $103.0 million.

  • Quest Diagnostics' Depreciation and Depletion rose 10.75% to $103.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $406.0 million, marking a year-over-year increase of 16.00%. This contributed to the annual value of $366.0 million for FY2024, which is 10.57% up from last year.
  • Latest data reveals that Quest Diagnostics reported Depreciation and Depletion of $103.0 million as of Q3 2025, which was down 0.96% from $104.0 million recorded in Q2 2025.
  • Quest Diagnostics' Depreciation and Depletion's 5-year high stood at $104.0 million during Q2 2025, with a 5-year trough of $74.0 million in Q1 2021.
  • Moreover, its 3-year median value for Depreciation and Depletion was $88.0 million (2024), whereas its average is $91.4 million.
  • As far as peak fluctuations go, Quest Diagnostics' Depreciation and Depletion increased by 23.33% in 2021, and later declined by 3.75% in 2022.
  • Over the past 5 years, Quest Diagnostics' Depreciation and Depletion (Quarterly) stood at $80.0 million in 2021, then fell by 3.75% to $77.0 million in 2022, then rose by 6.49% to $82.0 million in 2023, then increased by 19.51% to $98.0 million in 2024, then rose by 10.75% to $103.0 million in 2025.
  • Its Depreciation and Depletion was $103.0 million in Q3 2025, compared to $104.0 million in Q2 2025 and $101.0 million in Q1 2025.